Activation of the PBX2‐PRMT1‐SWI/SNF‐IGF2BP2 Signaling Pathway is Associated with Malignant Progression and Poor Prognosis of HNSCC. Here, IGF2BP2 is linked to head and neck squamous cell carcinoma.